UBS AM
CTEV

UBS AM’s Claritev Corp CTEV Stock Holding History

UBS AM’s Portfolio CTEV Stock Details CTEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,774
Closed -$198K – 2874
2024
Q2 		$198K Buy
12,774
+7,219
+130% +$172K ﹤0.01% 2755
2024
Q1 		$180K Hold
5,555
– – ﹤0.01% 2476
2023
Q4 		$320K Hold
5,555
– – ﹤0.01% 2413
2023
Q3 		$373K Hold
5,555
– – ﹤0.01% 2380
2023
Q2 		$236K Hold
5,555
– – ﹤0.01% 2536
2023
Q1 		$236K Hold
5,555
– – ﹤0.01% 2536
2022
Q4 		$256K Hold
5,555
– – ﹤0.01% 2377
2022
Q3 		$636K Sell
5,555
-1,406
-20% -$233K ﹤0.01% 2230
2022
Q2 		$1.53M Buy
6,961
+681
+11% +$135K ﹤0.01% 1743
2022
Q1 		$1.18M Buy
6,280
+1,890
+43% +$311K ﹤0.01% 2054
2021
Q4 		$778K Buy
4,390
+1,505
+52% +$268K ﹤0.01% 2348
2021
Q3 		$650K Hold
2,885
– – ﹤0.01% 2382
2021
Q2 		$1.1M Buy
+2,885
New +$894K ﹤0.01% 2150

Other funds holding CTEV

HFCIV
H&F Corporate Investors VIII San Francisco, California $133M AUM 24.42% 1-Year Est. Return
PIF
Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $37.9B AUM 7.98% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
AM
Ares Management Los Angeles, California $2.29B AUM 0.27% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $274M AUM 43.74% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $258M AUM 20.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

UBS AM's CTEV Position: Q3 2024 in Review

UBS AM sold out of Claritev Corp (CTEV) in Q3 2024, closing a stake of 12,774 shares — an estimated $198K sold.

UBS AM first reported a position in CTEV in Q2 2021 and held it in 13 quarters. The position peaked at $1.53M in Q2 2022. 60 funds tracked by Wall St. Rank hold CTEV as of Q3 2024.

  • UBS AM reported no remaining Claritev Corp position as of Q3 2024 after selling out during the quarter.
  • UBS AM sold 12,774 Claritev Corp shares in Q3 2024, an estimated $198K.
  • UBS AM first reported a position in Claritev Corp in Q2 2021 and held it in 13 quarters.
  • UBS AM's Claritev Corp position peaked at $1.53M in Q2 2022.
  • 60 funds tracked by Wall St. Rank held Claritev Corp as of Q3 2024.

Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.